Literature DB >> 30820909

Transmission Electron Microscopy of Oligodendrocytes and Myelin.

Marie-Theres Weil1,2,3, Torben Ruhwedel1, Martin Meschkat1, Boguslawa Sadowski1,2, Wiebke Möbius4,5.   

Abstract

In this chapter, we describe protocols to study different aspects of oligodendrocytes and myelin using electron microscopy. First, we describe in detail how to prepare central nervous system tissue routinely by perfusion fixation of the animal and conventional embedding in Epon resin. Then, we explain how, with some modifications, chemically fixed tissue can be used for immunoelectron microscopy on cryosections. Chemical fixation and Epon embedding can also be applied to purified myelin to assess the quality of the preparation. Furthermore, we describe how cryopreparation by high-pressure freezing can be used to study the fine structure of myelin in nerve, brain, and spinal cord tissue. The differences in the structural appearance of oligodendrocytes and myelin between cryopreserved and conventionally processed samples are compared using representative images. Since primary cultured oligodendrocytes are used to study structure and function in vitro, we provide protocols for chemical fixation and Epon embedding of these cultures. Finally, we explain how the cytoskeleton of cultured oligodendrocytes can be visualized by using transmission electron microscopy on platinum-carbon replicas. In this chapter, we provide a wide range of protocols that can be applied to shed light on the different biological aspects of myelin and oligodendrocytes.

Entities:  

Keywords:  Central nervous system; Chemical fixation; Cryopreparation; Cytoskeleton; Electron microscopy; Immunolabeling; Myelin; Oligodendrocytes

Mesh:

Year:  2019        PMID: 30820909     DOI: 10.1007/978-1-4939-9072-6_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43.

Authors:  Dongeun Heo; Jonathan P Ling; Gian C Molina-Castro; Abraham J Langseth; Ari Waisman; Klaus-Armin Nave; Wiebke Möbius; Phil C Wong; Dwight E Bergles
Journal:  Elife       Date:  2022-03-21       Impact factor: 8.713

2.  Neuronal activity disrupts myelinated axon integrity in the absence of NKCC1b.

Authors:  Katy L H Marshall-Phelps; Linde Kegel; Marion Baraban; Torben Ruhwedel; Rafael G Almeida; Maria Rubio-Brotons; Anna Klingseisen; Silvia K Benito-Kwiecinski; Jason J Early; Jenea M Bin; Daumante Suminaite; Matthew R Livesey; Wiebke Möbius; Richard J Poole; David A Lyons
Journal:  J Cell Biol       Date:  2020-07-06       Impact factor: 10.539

3.  CMTM6 expressed on the adaxonal Schwann cell surface restricts axonal diameters in peripheral nerves.

Authors:  Maria A Eichel; Vasiliki-Ilya Gargareta; Elisa D'Este; Robert Fledrich; Theresa Kungl; Tobias J Buscham; Katja A Lüders; Cristina Miracle; Ramona B Jung; Ute Distler; Kathrin Kusch; Wiebke Möbius; Swen Hülsmann; Stefan Tenzer; Klaus-Armin Nave; Hauke B Werner
Journal:  Nat Commun       Date:  2020-09-09       Impact factor: 14.919

4.  Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.

Authors:  Anastasia Dagkonaki; Maria Avloniti; Maria Evangelidou; Irini Papazian; Ioannis Kanistras; Vivian Tseveleki; Fotis Lampros; Theodore Tselios; Lise Torp Jensen; Wiebke Möbius; Torben Ruhwedel; Maria-Eleni Androutsou; John Matsoukas; Maria Anagnostouli; Hans Lassmann; Lesley Probert
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

Review 5.  Río-Hortega's drawings revisited with fluorescent protein defines a cytoplasm-filled channel system of CNS myelin.

Authors:  Julia M Edgar; Eleanor McGowan; Katie J Chapple; Wiebke Möbius; Leandro Lemgruber; Robert H Insall; Klaus-Armin Nave; Anne Boullerne
Journal:  J Anat       Date:  2021-10-28       Impact factor: 2.610

6.  White matter integrity in mice requires continuous myelin synthesis at the inner tongue.

Authors:  Martin Meschkat; Anna M Steyer; Marie-Theres Weil; Kathrin Kusch; Olaf Jahn; Lars Piepkorn; Paola Agüi-Gonzalez; Nhu Thi Ngoc Phan; Torben Ruhwedel; Boguslawa Sadowski; Silvio O Rizzoli; Hauke B Werner; Hannelore Ehrenreich; Klaus-Armin Nave; Wiebke Möbius
Journal:  Nat Commun       Date:  2022-03-04       Impact factor: 14.919

7.  Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patients.

Authors:  Luis Peter Haupt; Sabine Rebs; Wiebke Maurer; Daniela Hübscher; Malte Tiburcy; Steffen Pabel; Andreas Maus; Steffen Köhne; Rewati Tappu; Jan Haas; Yun Li; Andre Sasse; Celio C X Santos; Ralf Dressel; Leszek Wojnowski; Gertrude Bunt; Wiebke Möbius; Ajay M Shah; Benjamin Meder; Bernd Wollnik; Samuel Sossalla; Gerd Hasenfuss; Katrin Streckfuss-Bömeke
Journal:  Basic Res Cardiol       Date:  2022-03-08       Impact factor: 12.416

8.  Pathology of myelinated axons in the PLP-deficient mouse model of spastic paraplegia type 2 revealed by volume imaging using focused ion beam-scanning electron microscopy.

Authors:  Anna M Steyer; Torben Ruhwedel; Christos Nardis; Hauke B Werner; Klaus-Armin Nave; Wiebke Möbius
Journal:  J Struct Biol       Date:  2020-03-08       Impact factor: 2.867

9.  Intranasal mesenchymal stem cell therapy to boost myelination after encephalopathy of prematurity.

Authors:  Josine E G Vaes; Caren M van Kammen; Chloe Trayford; Annette van der Toorn; Torben Ruhwedel; Manon J N L Benders; Rick M Dijkhuizen; Wiebke Möbius; Sabine H van Rijt; Cora H Nijboer
Journal:  Glia       Date:  2020-10-12       Impact factor: 7.452

10.  Structural myelin defects are associated with low axonal ATP levels but rapid recovery from energy deprivation in a mouse model of spastic paraplegia.

Authors:  Andrea Trevisiol; Kathrin Kusch; Anna M Steyer; Ingo Gregor; Christos Nardis; Ulrike Winkler; Susanne Köhler; Alejandro Restrepo; Wiebke Möbius; Hauke B Werner; Klaus-Armin Nave; Johannes Hirrlinger
Journal:  PLoS Biol       Date:  2020-11-16       Impact factor: 8.029

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.